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Abstract
Lyme borreliosis is a common tick-borne disease with a wide
variety of clinical manifestations. Cardiac involvement has been
reported during both the acute phase (atrioventricular block,
pericarditis) and the chronic stage (dilated cardiomyopathy), but
is rare (<5%). Here we describe the first case of Borrelia afzelii
Lyme endocarditis, in a 61-year-old man living in an endemic
area of France. The diagnosis was confirmed by detection of B.
afzelii DNA in the mitral valve by specific real-time PCR. He
was treated empirically with amoxicillin for 6 weeks and remains
well 12 months later.
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Lyme borreliosis (or Lyme disease) is the most commonly
reported tick-borne disease in the northern hemisphere,
notably in Europe and North America. The different species
of the Borrelia burgdorferi sensu lato group are transmitted by
infected ticks of the genus Ixodes. Whereas only one bacte-
rial species, B. burgdorferi sensu stricto, is currently recog-
nized as pathogenic in North America, several pathogenic
species are present in Europe (mainly B. burgdorferi sensu
stricto, B. afzelii and B. garinii), where they cause a wider
variety of clinical manifestations [1]. Typically, following initial
erythema migrans at the tick bite site, these bacteria can
spread from the skin to other tissues and organs, causing
more severe manifestations such as arthritis and cutaneous
and neurological disorders [2]. Cardiac Lyme borreliosis is
rare, representing only 0.3–4% of cases in Europe, and is
generally associated with acute-onset atrioventricular (I–III)
conduction disorders, arythmias and, in some cases, myocar-
ditis or pericarditis [3–8]. Here we describe a documented
case of Lyme endocarditis.
A 61-year-old man was admitted in March 2011 to
Limoges University Hospital, France, for mitral valve replace-
ment. He was an ex-smoker, had a history of paroxystic
auricular fibrillation, and had mitral insufficiency due to mitral
valve prolapse. Initial investigations showed auricular fibrilla-
tion and dyspnoea, mitral regurgitation with rope rupture, an
ejection fraction of 45%, and a dilated left atrium on cardiac
ultrasound. During surgery the macroscopic aspect of the
mitral valve suggested endocarditis, with prolapse of the pos-
terior valve and a 5-mm2 perforation of the anterior valve.
All blood cultures and serologies commonly performed in
the case of endocarditis (Bartonella henselae, Bartonella quin-
tana, Mycoplasma pneumoniae, Legionella pneumophila,
Chlamydophila pneumoniae and Coxiella burnetii) were all nega-
tive. He was treated empirically with intravenous amoxicillin
and gentamicin for 2 weeks, followed by oral amoxicillin for
4 weeks. Microscopic analysis of the mitral valve showed
endocarditis with foamy macrophages suggestive of intracel-
lular microorganisms (Photo 1). Gram, PAS and Gimenez
PHOTO 1 Microscopic view of the mitral valve showing surface
fibrin deposit, and sparse inflammatory infiltrate consisting of foamy
macrophages, neutrophils and eosinophils (hematein eosin saffron
·400).
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stains were negative. Whartin-Starry stain showed only
scarce curved rods, which had a morphology that was not
specific to Spirochaetes. Universal PCR targeting 16S RNA-
encoding DNA was applied to a valve fragment and the
amplification product was sequenced, identifying the genus
Borrelia. Two valve fragments were sent to the French Bor-
relia National Reference Center for confirmation. Both were
positive by specific real-time PCR using a Taqman probe
targeting a conserved region of the flagellin (Fla) gene of the
Borrelia burgdorferi sensu lato (Bbsl) complex [9]. Further real-
time DNA amplification using hybridization probes targeting
species-specific regions of the fla gene identified B. afzelii.
The Anti-Borrelia Plus VlsE ELISA IgG assay was positive and
the Anti-Borrelia ELISA IgM assay was negative (both tests
from Euroimmun AG, Luebeck, Germany). Western blot
(Borrelia afzelii + VlsE Eco Blot IgG Western Blot; Virotech,
Ru¨sselsheim, Germany) confirmed the presence of several
antibodies targeting the VlsE, p83, p58, p39, p31 and p21
proteins. Only atrial fibrillation persisted after antibiotic
treatment, with no mitral regurgitation. As the patient was
well, and given the lack of specific therapeutic guidelines for
Lyme endocarditis, antibiotic treatment was not prolonged
or changed. The patient did not recall a tick bite, a previous
episode of erythema migrans, or secondary manifestations
such as meningoradiculitis.
To our knowledge this is the first documented case of
B. afzelii Lyme endocarditis. In Europe, B. afzelii is commonly
associated with neurological and late cutaneous manifesta-
tions, and less frequently with arthritis. Only one previous
publication mentions detection of the weakly pathogenic spe-
cies B. bissettii in a patient’s cardiac valve tissue, in the Czech
Republic, without mentioning Lyme endocarditis diagnosis
[10]. Borreliosis is endemic in our patient’s home region
(Limousin), with an estimated seroprevalence of 42 cases per
100 000 inhabitants [11]. B. burgdorferi seropositivity is very
common in endemic areas, and cannot serve as a definitive
diagnostic criterion, as underlined by Kaell et al. [12] and Sta-
nek et al. [2]. The exceptional case of Lyme endocarditis
described here emphasizes the need to perform universal
PCR on heart valve samples in the case of endocarditis of
unknown origin, and to bear in mind the possibility of borre-
lial aetiology in endemic areas.
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